Winthrop P. Rockefeller Cancer Institute
July 30, 2026
UAMS to Purchase Proton Center of Arkansas
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) announced today that it is purchasing the Proton Center of Arkansas, allowing UAMS to immediately resume offering proton therapy to all Arkansans.
July 23, 2026
UAMS Faces Obstacles in its Efforts to Save Proton Center of Arkansas
LITTLE ROCK — While the University of Arkansas for Medical Sciences (UAMS) is working to save the Proton Center of Arkansas (PIA) from closure, numerous obstacles continue to imperil the operation, said UAMS Chancellor C. Lowry Barnes, M.D.
July 14, 2026
Subaru of Little Rock, Blood Cancer United Show Support for UAMS Blood Cancer Patients
Subaru of Little Rock and Blood Cancer United continued their long-standing collaboration with the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute with donations for patients undergoing blood cancer treatment.
May 12, 2026
Be A Part of the Cure Walk Raises More Than $500,000 for Cancer Research
The Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) hosted the sixth annual Be A Part of the Cure Walk on Saturday, May 2, at War Memorial Stadium in Little Rock.
April 30, 2026
UAMS Radiation Oncology Center Receives $200,000 Grant from Ottenheimer Brothers Foundation
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) received a $200,000 grant from the Ottenheimer Brothers Foundation to support the UAMS Winthrop P. Rockefeller Cancer Institute’s Radiation Oncology Center. The grant will go to the purchase and installation of the Brainlab ExacTrac Dynamic System. The medical equipment and software combine surface and…
April 24, 2026
Behind the Scenes
Majid Asgari, Ph.D. Majid Asgari, Ph.D., is a postdoctoral fellow in the UAMS College of Medicine Department of Internal Medicine. He earned his doctorate in medical biotechnology from the Pasteur Institute of Iran in 2021 and joined the UAMS Myeloma Center in 2024 in the lab of research director Fenghuang “Frank” Zhan, M.D., Ph.D. His…
Publications
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages Blood Cancer Journal November 2024 Primary authors: Yan Cheng, Ph.D.; Fumou Sun, Ph.D. Tumor immune microenvironmental alterations occur early in multiple myeloma development. In this study, we aim to systematically characterize the tumor immune microenvironment (TME) and the tumor-immune interactions from precursor stages,…
Infusion B: A Welcoming Setting for Blood Cancer Patients
Five years after its opening, Infusion B at the Winthrop P. Rockefeller Cancer Institute continues to play a vital role in the transformational care that blood cancer patients receive at the University of Arkansas for Medical Sciences (UAMS).
Myeloma Patient Thankful for Chance to Participate in Clinical Trial
Gary Robertson thinks his multiple myeloma diagnosis came at good time, if such a thing is possible.
Cancer Institute’s Clinical Research Team Guides Myeloma Clinical Trials
The Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) is the state’s leader in cancer clinical trials. Clinical trials are conducted for purposes such as studying new drugs or drug combinations, reviewing a new method of performing surgeries or using existing treatments, or researching ways to prevent diseases.
Next page